Study Name: A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
26 locations found
- Teva Investigational Site 12
Location: Anaheim, California
- Teva Investigational Site 11
Location: Fountain Valley, California
- Teva Investigational Site 43
Location: Los Angeles, California
- Teva Investigational Site 4
Location: Orange, California
- Teva Investigational Site 15
Location: Walnut Creek, California
- Teva Investigational Site 2
Location: Colorado Springs, Colorado
- Teva Investigational Site 24
Location: Largo, Florida
- Teva Investigational Site 5
Location: Miami, Florida
- Teva Investigational Site 27
Location: Miami, Florida
- Teva Investigational Site 19
Location: Tallahassee, Florida
- Teva Investigational Site 17
Location: Trinity, Florida
- Teva Investigational Site 18
Location: Valrico, Florida
- Teva Investigational Site 6
Location: Lilburn, Georgia
- Teva Investigational Site 3
Location: Savannah, Georgia
- Teva Investigational Site 7
Location: Iowa City, Iowa
- Teva Investigational Site 8
Location: Omaha, Nebraska
- Teva Investigational Site 26
Location: Summit, New Jersey
- Teva Investigational Site 20
Location: Cincinnati, Ohio
- Teva Investigational Site 1
Location: Medford, Oregon
- Teva Investigational Site 73
Location: Lincoln, Rhode Island
- Teva Investigational Site 9
Location: Providence, Rhode Island
- Teva Investigational Site 21
Location: Charleston, South Carolina
- Teva Investigational Site 16
Location: Fort Worth, Texas
- Teva Investigational Site 10
Location: Houston, Texas
- Teva Investigational Site 45
Location: San Antonio, Texas
- Teva Investigational Site 14
Location: San Antonio, Texas
|